Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Health
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
The Pharmalot View
STAT+

Biden wants to bolster the pharma supply chain. A major generic plant closing may make that harder

  • Ed Silverman

By Ed Silverman July 27, 2021

Reprints
pharmaceutical plant closure
Adobe

If you think bolstering the pharmaceutical supply chain in the U.S. is a national priority, you could be wrong.

Just take a look at the sorry situation in Morgantown, W. Va.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

Create a display name to comment

This name will appear with your comment

People with terminal cancer need to know they are…
People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information
Your questions on the new Covid vaccine boosters answered
Your questions on the new Covid vaccine boosters answered
Comparing the Pfizer and Moderna Covid vaccines for young…
Comparing the Pfizer and Moderna Covid vaccines for young children
Pharmalittle: Illumina faces more challenges after winning FTC case;…
Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics
Rahul Gupta, first physician to serve as drug czar,…
Rahul Gupta, first physician to serve as drug czar, says stigma among doctors is key culprit…
Pharmalittle: FDA authorizes new Covid boosters; a setback for…
Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

Recommended Stories